Abstract. ␣-Synuclein has an important role in the pathogenesis of Parkinson disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), comprising a new disease concept, that of ␣-synucleinopathies. Cerebellar degeneration with Purkinje cell depletion is present in the majority of MSA cases. By contrast, cerebellar pathology has not been demonstrated unequivocally in either PD or DLB. Recent immunohistochemical studies using anti-␣-synuclein antibodies have shown that LB-type degeneration in PD and DLB is more widespread than previously recognized. To determine whether cerebellar Purkinje cells might be involved in ␣-synuclein pathology, we carried out immunohistochemical examinations of the cerebella of patients with PD (n ϭ 10), DLB (n ϭ 7), MSA (n ϭ 10), Alzheimer disease and other tauopathies (n ϭ 9), and age-matched control subjects (n ϭ 10), using antibodies specific for ␣-synuclein. Although no abnormal accumulation of ␣-synuclein was noted in the Purkinje cell somata, numerous ␣-synucleinpositive, round inclusions were found in the cerebellar white matter in all the patients with PD and DLB. Immunohistochemical and ultrastructural examinations revealed that the majority of these inclusions was located in the Purkinje cell axons and consisted of granulo-filamentous structures. No such inclusions were observed in MSA, tauopathies, or controls. These findings indicate that Purkinje cells are also the victims of ␣-synuclein pathology in PD and DLB, but not in MSA.
INTRODUCTION
The discovery of point mutations in the ␣-synuclein gene in some families with autosomal dominantly inherited Parkinson disease (PD) (1, 2) together with the identification of ␣-synuclein as the major component of Lewy bodies (LBs) and related axonal changes (Lewy neurites) in the brains of patients with PD and dementia with LBs (DLB) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) have strongly implicated ␣-synuclein in the pathogenesis of LB disorders. Subsequently, it has become evident that glial cytoplasmic inclusions (which are oligodendroglial in origin) in multiple system atrophy (MSA) also contain ␣-synuclein (14) (15) (16) (17) (18) (19) . Thus, LB disorders and MSA comprise a new disease concept, namely that of ''␣-synucleinopathies.'' It is now known that the ␣-synuclein deposited in ␣-synucleinopathic lesions is extensively phosphorylated (20) .
Cerebellar degeneration with Purkinje cell depletion is present in the majority of MSA cases. On the other hand, there have been few reports with respect to the morphological changes in the cerebellum in patients with PD and DLB (21) (22) (23) . Recent immunohistochemical studies using anti-␣-synuclein antibodies have shown that LB-type degeneration in PD and DLB is more widespread than previously recognized. In addition to the cerebral cortex and brainstem pigmented nuclei, LBs are also found in the pontine, inferior olivary and cerebellar dentate nuclei, the spinal gray matter, and the visceral autonomic nervous system (23, 24) . ␣-Synuclein-positive inclusions in both astrocytic and oligodendroglial cells have also been detected in PD and DLB brains (23, (25) (26) (27) (28) . Furthermore, we have found ␣-synuclein-positive inclusions in the Bergmann glia of the cerebellum in patients with ␣-synucleinopathies (29) . In the work presented here, we report a new finding: cerebellar Purkinje cells are affected by the filamentous accumulation of ␣-synuclein in PD and DLB, but not in MSA.
MATERIALS AND METHODS

Subjects
Forty-six autopsy cases were used for the present study (Table  1) : MSA (n ϭ 10), PD (n ϭ 10), DLB (n ϭ 7), Alzheimer disease (n ϭ 2), Pick disease (n ϭ 2), corticobasal degeneration (n ϭ 2), progressive supranuclear palsy (n ϭ 2), frontotemporal dementia PD  PD  PD  PD  PD  PD  PD  PD  PD  PD   68  67  76  74  73  68  61  81  75  78   F  M  M  F  M  M  M  M  M  F   9  5  15  6  21  13  30  18  27  14   4  4  4  4  4  4  3  3  4  3   0  3  2  3  5  3  2  3  2  1   I  I  I  II  II  I  I  I  II  II   A  0  0  A  0  0  0  0  A  0   22  52  99  77  5  17  46  2  50  9  11  12  13  14  15  16  17   DLB  DLB  DLB  DLB  DLB  DLB  DLB   74  70  64  78  74I  I  I  I  II  II  I   C  B  B  A  B  A  A   5  106  55  66  6  107  16  18  19  20  21  22  23  24  25  26 (n ϭ 1), and age-matched controls (n ϭ 10). Patients with a predominant cerebellar syndrome were defined as having MSA of olivopontocerebellar atrophy type, those with a predominant parkinsonism were defined as having MSA of striatonigral degeneration type, and those with a predominant autonomic dysfunction were defined as having MSA of the Shy-Drager syndrome type. The diagnoses were confirmed both clinically and histopathologically. All 46 specimens additionally were classified according to procedures permitting differentiation among stages 1 to 6 of PDrelated pathology ( (31), stages I to VI of neurofibrillary changes (32) , and stages A to C of amyloid-␤ deposition (32) ( Table 1) .
Immunohistochemistry
In each case, 4-m-thick, formalin-fixed, paraffin-embedded mid-sagittal sections of the unilateral cerebellar hemisphere, including the dentate nucleus, were prepared and immunostained using the avidin-biotin-peroxidase complex method (Vectastain kit; Vector, Burlingame, CA). Diaminobenzidine was used as the chromogen. The following antibodies and dilutions were used: anti-␣-synuclein (NACP-6; 1:10,000) (29), anti-phosphorylated ␣-synuclein (anti-PSer129; 1:400) (20) , anti-␤-synuclein (NACP-4; 1:1,000) (28), anti-calbindin-D (Sigma, St. Louis, MO; 1:1,000), anti-ubiquitin (Dako, Glostrup, Denmark; 1:800), anti-phosphorylated neurofilament (SMI31; Sternberger Immunochemicals, Baltimore, MD; 1:1,000), anti-phosphorylated tau (AT8; Innogenetics, Ghent, Belgium; 1:1,000), antityrosine hydroxylase (Boehringer Mannheim, Mannheim, Germany; 1:500), and anti-glial fibrillary acidic protein (GFAP; Dako; 1:400).
Selected sections were pretreated with proteinase K (Gibco BRL, Gaithersburg, MD) at a concentration of 10 g/ml in 0.1 M TRIS-HCl buffer, pH 7.5, with 5 mM ethylenediamine tetraacetic acid for 10 min at room temperature or 99% formic acid (Wako, Osaka, Japan) for 5 min at room temperature.
To characterize the inclusion-bearing processes, anti-calbindin-D was used as the marker of Purkinje cells. In the PD brains, 50-m-thick vibratome sections of the cerebellum were immunostained with combinations of NACP-6 (1:1,000) and anti-calbindin-D (Sigma; 1:40). The secondary antibodies used were fluorescein-isothiocyanate-conjugated anti-mouse IgG (Vector; 1:50) and biotinylated anti-rabbit IgG (Vector; 1:50), followed by rhodamine-conjugated avidin D (Vector; 1:100). The sections were examined with the aid of a laser confocal microscope (LSM 410, Carl Zeiss, Jena, Germany).
Immunoelectron Microscopy
Cerebellar tissue from a 76-year-old man with PD of 15 years duration was processed for immunoelectron microscopy. Fiftym-thick vibratome sections were cut from the formalin-fixed cerebellar tissue and incubated with NACP-6 (1:10,000) and then processed as reported previously (29) .
Semiquantitative Analysis
The total numbers of inclusions immunostained with ␣-synuclein in the cerebellar cortex and white matter in each case were measured. To avoid counting glial inclusions, ␣-synucleinpositive structures attaching or overlapping glial nuclei were excluded. Statistical analysis was done with STATVIEW II (Abacus Concepts Inc., Berkeley, CA) software on a Macintosh personal computer. Comparisons among PD, DLB, and MSA were performed with analysis of variance.
RESULTS
Round, ␣-synuclein-positive inclusions were found in the cerebellum in all the patients with PD and DLB (Fig.  1A-D) . No such inclusions were observed in tissues from patients with MSA, Alzheimer disease, Pick disease, corticobasal degeneration, progressive supranuclear palsy or frontotemporal dementia, or from controls even after pretreatment with either proteinase K or formic acid. Serial sections stained with anti-␣-synuclein and hematoxylin and eosin revealed that these inclusions were associated with round-to-oval, eosinophilic structures with a neuritic LB-like appearance (Fig. 1E) . These round, ␣-synucleinpositive inclusions were numerous in the cerebellar white matter (medullary core), while very few were observed in the cerebellar cortex (Fig. 2) . They could easily be differentiated from the doughnut-shaped inclusions that are characteristic of Bergmann glia morphology (Fig.  1F) ; the latter were confined to the molecular layer and were immunopositive for GFAP (29) . No abnormal accumulation of ␣-synuclein was noted in the Purkinje cell somata. The number of ␣-synuclein-positive, round inclusions in the cerebellum was counted in one 4-m-thick section in each case (Table 1 ). There was no significant difference in the average number of inclusions between PD and DLB ( Table 2) .
Since previous studies have shown that pretreatment with either proteinase K or formic acid enhances ␣-synuclein immunoreactivity (33-35), we performed immunolabeling with anti-␣-synuclein antibodies after such pretreatment. This pretreatment slightly enhanced the level of ␣-synuclein immunoreactivity, especially in glial cytoplasmic inclusions in MSA, but had no effect on the numbers of ␣-synuclein-positive, round inclusions.
The double-labeling immunofluorescence study revealed that approximately 70% to 80% of round, ␣-synuclein-positive inclusions were located in the calbindin-D-positive cell processes in the cerebellar cortex and white matter (Fig. 1G-L) , suggesting that they originate in the dendrites and axons of Purkinje cells.
␣-Synuclein-positive neuritic inclusions, doughnutshaped inclusions in the Bergmann glia (29) , and coillike glial inclusions in the white matter (25) (26) (27) (28) were also immunolabeled with anti-PSer129 (Fig. 1M-O) , suggesting that these inclusions contain the extensively phosphorylated ␣-synuclein as a highly pathologic event. ␣-Synuclein-positive neuritic inclusions were also positive for phosphorylated neurofilament and ubiquitin and negative for ␤-synuclein, phosphorylated tau, tyrosine hydroxylase, and GFAP.
Pre-embedding immunoelectron microscopy revealed that round, ␣-synuclein-positive inclusions in the axons and dendrites consisted of granulo-filamentous structures (Fig. 3) . Occasionally, ␣-synuclein-positive structures observed in axons were surrounded by bundles of neurofilament.
DISCUSSION
In the present study, numerous round, ␣-synuclein-positive inclusions were found in the Purkinje cell axons in all of the patients with PD and DLB. Ultrastructurally, these inclusions consisted of randomly arranged granulofilamentous structures. The ultrastructural features are very similar to those of Lewy neurites observed in the hippocampal CA2/3 regions (36). To our knowledge, this is the first demonstration of ␣-synuclein pathology in the Purkinje cells. Moreover, it has not hitherto been reported that GABA-ergic neurons such as Purkinje cells are involved in the disease process of LB disorders.
Aggregated neurofilament subunits and ␣-synuclein are the major protein components of LBs (37, 38) . In the present study, ␣-synuclein inclusions in the Purkinje cell axons were also positive for phosphorylated neurofilament. Tu et al (39) reported that transgenic mice expressing a fusion protein composed of a truncated high-molecular-weight mouse neurofilament protein fused to ␤-galactosidase develop LB-like inclusions in neuronal somata in the cerebral cortex and cerebellar Purkinje cells. Recently, several transgenic mice expressing wildtype human ␣-synuclein were generated to elucidate the role of ␣-synuclein accumulation in the pathogenesis of ␣-synucleinopathies (40) (41) (42) (43) . These studies demonstrated widespread accumulation of ␣-synuclein in the neuronal somata and processes, similar to aberrant ␣-synuclein localization noted in the brainstem and cortical neurons in PD and DLB. Kahle et al (42) reported that ␣-synuclein abnormally accumulated in neuronal cell bodies and neurites in most brain areas, including the cerebellar Purkinje cells, in ␣-synuclein transgenic mice. Thus, Purkinje cells are also affected by the accumulation of ␣-synuclein in human LB disorders and transgenic mice.
In the present study, however, approximately 20% to 30% of ␣-synuclein-positive neuritic inclusions were not located in the Purkinje cells. The cerebellar white matter is mainly composed of the following nerve fibers: intrinsic fibers of the Purkinje cells, afferent fibers from the pontine and inferior olivary nuclei, and efferent fibers from the dentate nucleus. Kakita et al (22) described the occurrence of LBs in the dentate nucleus in a patient with PD. Piao et al (23) reported that ␣-synuclein-positive spherical inclusions are frequently found in neurons in the dentate, inferior olivary, and pontine nuclei in patients with DLB. It is possible that abnormal accumulations of ␣-synuclein also occur in the efferent and afferent fibers of the cerebellum in PD and DLB.
Functional imaging studies have revealed abnormalities in the changes in activity associated with gait and hand movements in the cerebellum of PD patients (44, 45) . Hanakawa et al (44) demonstrated, using single photon emission computed tomography, that changes in gait on a treadmill induce reduced levels of activation in the cerebellar hemisphere in patients with PD. Rascol et al (45) also showed that the ipsilateral cerebellar hemisphere was overactive in PD patients when they performed a motor task. Mild atrophy of the cerebellar vermis and/or hemispheres was identified in 6 of 21 patients with PD by magnetic resonance imaging (46) . Cerebral activation studies not only confirm altered function of corticostriatalthalamocortical loops in PD, but also emphasize the importance of networks involving the cerebellum (47, 48) . Considering that the majority of LB-containing nerve cell processes are axons, it is possible to consider that ␣-synuclein lesions disrupt axonal transport of affected neurons. ␣-Synuclein pathology in the cerebellum might be related to the cerebellar dysfunctions described herein or to the movement disorders observed in PD patients.
In the brains of patients affected by MSA, numerous glial cytoplasmic inclusions are distributed widely in the central nervous system, including the cerebellar white matter. Abnormal accumulations of ␣-synuclein are also found in the neuronal somata and processes in the pontine nucleus and, to a lesser degree, in the inferior olivary nucleus and putamen (19) . Despite extensive search, no ␣-synuclein accumulation was noted in the somata or processes of Purkinje cells in the present study, suggesting that degeneration and loss of Purkinje cells is not due to ␣-synuclein accumulation. In MSA, apoptosis occurs almost exclusively in oligodendrocytes, the distribution of cell death being comparable to that of glial cytoplasmic inclusions (49) . Extensive myelin degeneration has also been demonstrated to occur in the MSA brain (50) These findings suggest that in MSA, Purkinje cells are affected secondarily through damage to the oligodendrocytes and myelin in the cerebellar white matter.
In conclusion, cerebellar Purkinje cells are victims of ␣-synuclein pathology in PD and DLB, whereas Purkinje cell depletion is not due to ␣-synuclein accumulation in MSA.
